Christopher Flint O'Brien
Directeur/Membre du Conseil chez Verifax Corp.
Profil
Christopher Flint O'Brien is currently a Director at Verifax Corp.
He previously worked as Chairman-Medicine Department at Swedish Health Services, Medical Director at Colorado Neurological Institute and National Parkinson Foundation, Inc. He also served as Chief Medical Officer at Neurocrine Biosciences, Inc. from 2014 to 2018, at Prestwick Pharmaceuticals, Inc. from 2003 to 2005, and at Elan Pharmaceuticals, LLC from 2000 to 2003.
Additionally, he was an Associate Professor at The University of Colorado.
O'Brien received his undergraduate degree from Boston University and his doctorate from the University of Minnesota.
Postes actifs de Christopher Flint O'Brien
Sociétés | Poste | Début |
---|---|---|
Verifax Corp. | Directeur/Membre du Conseil | 30/06/2010 |
Anciens postes connus de Christopher Flint O'Brien
Sociétés | Poste | Fin |
---|---|---|
NEUROCRINE BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 08/01/2018 |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Directeur Technique/Scientifique/R&D | 01/01/2005 |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Directeur Technique/Scientifique/R&D | 01/01/2003 |
The University of Colorado | Corporate Officer/Principal | - |
National Parkinson Foundation, Inc. | Directeur Technique/Scientifique/R&D | - |
Formation de Christopher Flint O'Brien
Boston University | Undergraduate Degree |
University of Minnesota | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
NEUROCRINE BIOSCIENCES, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Health Technology |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
Swedish Health Services
Swedish Health Services Hospital/Nursing ManagementHealth Services Swedish Health Services provides health care services. The company was founded in 1910 and is headquartered in Seattle, WA. | Health Services |
Colorado Neurological Institute
Colorado Neurological Institute Medical/Nursing ServicesHealth Services Colorado Neurological Institute provided healthcare services. It offered remedial care and services for adults with neurological disorders and children with hearing loss and ear diseases. The organization was founded in 1988 and was headquartered in Englewood, CO. | Health Services |
National Parkinson Foundation, Inc. | Health Technology |
Verifax Corp. |